Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells

Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells

We previously published the results of a pilot study showing that vaccination with tumor-loaded dendritic cells (DCs) induced both T and B cell response and produced clinical benefit in the absence of toxicity in patients with relapsed, indolent non-Hodgkin lymphoma (iNHL). The purpose of the presen...

Full description

Bibliographic Details
Main Authors: Filippo de Braud, Francesca De Santis, Roberta Zappasodi, Massimo Di Nicola, Margherita Ambrosini, Michele Magni, Luca Agnelli, Silvia Brich, Francesco Sgambelluri, Roberta Mortarini, Serenella M Pupa, Liliana Devizzi, Paola Matteucci, Antonello Cabras, Andrea Anichini, Alessandro M Gianni
Format: Article
Language:English
Published: BMJ Publishing Group 2021-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/6/e002240.full

Internet

https://jitc.bmj.com/content/9/6/e002240.full

Similar Items